Sosnowski Robert Edward 4/A
4/A · Cyclacel Pharmaceuticals, Inc. · Filed Jan 8, 2009
Insider Transaction Report
Form 4/AAmended
Sosnowski Robert Edward
VP, Marketing & Sales
Transactions
- Award
Option
2008-11-18+100,000→ 100,000 totalExercise: $0.44Exp: 2018-11-18→ Common Stock (100,000 underlying)
Footnotes (2)
- [F1]These options are exercisable over a three-year period, with one-third (1/3) of the options granted vesting on November 18, 2009, the first anniversary of the grant date, and the balance of the options granted vesting ratably on a monthly basis over the following 24 months.
- [F2]These securities were issued as part of the Issuer's annual equity compensation to executive officers.